mhurhangee/patent-ind-claim-en huggingface dataset:
Sensor device for determining and/or monitoring a process variable of a medium in a container , comprising - a crystal body with at least one defect , - a magnetic field device for generating a magnetic field, wherein the magnetic field device is arranged in such a way that a magnetic field (B) can be generated by means of the magnetic field device in the region of the crystal body and in the region of the medium located inside the container , and wherein the crystal body and the magnetic field device can be arranged from the outside on a wall of the container , - a detection unit for detecting a magnetic field-dependent fluorescence signal from the crystal body , wherein the detection unit has an excitation unit for optical excitation of the defect and a detector for detecting the fluorescence signal , and - an evaluation unit for determining at least one statement about the process variable on the basis of the fluorescence signal . - a crystal body with at least one defect , - a magnetic field device for generating a magnetic field, wherein the magnetic field device is arranged in such a way that a magnetic field (B) can be generated by means of the magnetic field device in the region of the crystal body and in the region of the medium located inside the container , and wherein the crystal body and the magnetic field device can be arranged from the outside on a wall of the container , wherein the magnetic field device is arranged in such a way that a magnetic field (B) can be generated by means of the magnetic field device in the region of the crystal body and in the region of the medium located inside the container , and wherein the crystal body and the magnetic field device can be arranged from the outside on a wall of the container , - a detection unit for detecting a magnetic field-dependent fluorescence signal from the crystal body , wherein the detection unit has an excitation unit for optical excitation of the defect and a detector for detecting the fluorescence signal , and - an evaluation unit for determining at least one statement about the process variable on the basis of the fluorescence signal .
A sulfonic acid salt composition comprising compounds of formula (I) wherein n is 1 or 2, R 1 is H or C 1 -C 6 alkyl, R 2 is COOM, SO 3 M or CH(OH)SO 2 -OM, each M is an equivalent of a multivalent metal, and the molar ratio of a compound wherein n is 1 to a compound wherein n is 2 is below 0.1. n is 1 or 2, R 1 is H or C 1 -C 6 alkyl, R 2 is COOM, SO 3 M or CH(OH)SO 2 -OM, each M is an equivalent of a multivalent metal, and the molar ratio of a compound wherein n is 1 to a compound wherein n is 2 is below 0.1.
A photovoltaic system, comprising a controller and two groups of inverters, wherein the two groups of inverters comprise a positive inverter group and a negative inverter group; the positive inverter group comprises the following at least two inverters: a first inverter and a third inverter ; the negative inverter group comprises the following at least two inverters: a second inverter and a fourth inverter ; alternating current output ends of the first inverter and the third inverter are connected in parallel; direct current input ends of the first inverter and the second inverter are connected in series; alternating current output ends of the second inverter and the fourth inverter are connected in parallel; and direct current input ends of the third inverter and the fourth inverter are connected in series; and the controller is specifically configured to: obtain a circulating current between at least two inverters whose alternating current output ends are connected in parallel; and when the circulating current is greater than a preset current threshold or a rising rate of the circulating current is greater than a preset rate, control all inverters whose corresponding alternating current output ends are connected in parallel to undergo wave blocking, wherein the wave blocking means that all power components of the inverters stop a switching action. the two groups of inverters comprise a positive inverter group and a negative inverter group; the positive inverter group comprises the following at least two inverters: a first inverter and a third inverter ; the negative inverter group comprises the following at least two inverters: a second inverter and a fourth inverter ; alternating current output ends of the first inverter and the third inverter are connected in parallel; direct current input ends of the first inverter and the second inverter are connected in series; alternating current output ends of the second inverter and the fourth inverter are connected in parallel; and direct current input ends of the third inverter and the fourth inverter are connected in series; and the controller is specifically configured to: obtain a circulating current between at least two inverters whose alternating current output ends are connected in parallel; and when the circulating current is greater than a preset current threshold or a rising rate of the circulating current is greater than a preset rate, control all inverters whose corresponding alternating current output ends are connected in parallel to undergo wave blocking, wherein the wave blocking means that all power components of the inverters stop a switching action.
Tumble dryer comprising a laundry drum for receiving laundry to be dried, and at least one heating unit which is designed and arranged so as to heat the laundry drum , and a liquid dispensing unit which is oriented towards the upper region of the laundry drum , is designed as a spray unit and is arranged so as to spray a liquid onto the inner face of the laundry drum , characterised in that the heating unit is stationarily arranged radially outside the laundry drum as a contactless heating unit and is designed as an induction heating unit , the contactless heating unit and the liquid dispensing unit being arranged so as to be offset from one another in the circumferential direction (U) of the laundry drum , the liquid dispensing unit being arranged downstream of the heating unit in the direction of rotation V of the laundry drum .
A communication apparatus comprising: a reading unit configured to read an image relating to a first other communication apparatus and configured to read an image relating to a second other communication apparatus ; a first acquisition unit configured to acquire (S605) information on a public key of the first other communication apparatus from an image read by the reading unit relating to the first other communication apparatus; a second acquisition unit configured to acquire (S605) information on the second other communication apparatus from a second image read by the reading unit relating to the second other communication apparatus ; a transmitting unit configured to transmit (S613) information about a communication channel to the first other communication apparatus by cryptography using cryptographic key based on the public key of the first other communication apparatus , the communication channel being selected by the communication apparatus and being for use in a role determination process for determining roles of the first other communication apparatus and the second other communication apparatus in direct wireless communication; and to transmit (S615) the information about the communication channel and the information on the public key of the first other communication apparatus acquired by the first acquisition unit to the second other communication apparatus . a reading unit configured to read an image relating to a first other communication apparatus and configured to read an image relating to a second other communication apparatus ; a first acquisition unit configured to acquire (S605) information on a public key of the first other communication apparatus from an image read by the reading unit relating to the first other communication apparatus; a second acquisition unit configured to acquire (S605) information on the second other communication apparatus from a second image read by the reading unit relating to the second other communication apparatus ; a transmitting unit configured to transmit (S613) information about a communication channel to the first other communication apparatus by cryptography using cryptographic key based on the public key of the first other communication apparatus , the communication channel being selected by the communication apparatus and being for use in a role determination process for determining roles of the first other communication apparatus and the second other communication apparatus in direct wireless communication; and to transmit (S615) the information about the communication channel and the information on the public key of the first other communication apparatus acquired by the first acquisition unit to the second other communication apparatus .
A composition comprising (a) a molecule, N -(3-chloro-1-(pyridin-3-yl)-1 H- pyrazol-4-yl)-2-(methylsulfonyl)propanamide, having the following formula (Formula One): and N-oxides, agriculturally-acceptable acid addition salts, salt derivatives, solvates, ester derivatives, polymorphs, isotopes, resolved stereoisomers, and tautomers, and radionuclides thereof; and (b) an active ingredient selected from the group consisting of abamectin, acephate, acetamiprid, afidopyropen, bifenthrin, broflanilide, chlorantraniliprole, cyantraniliprole, cyclaniliprole, dimpropyridaz, dinotefuran, emamectin benzoate, ethiprole, flonicamid, fluazaindolizine, flubendiamide, fluensulfone, fluopyram, flupyradifurone, isocycloseram, lambda-cyhalothrin, spinetoram, spiromesifen, spiropidion, spirotetramat, sulfoxaflor, tetraniliprole, tioxazafen, and triflumezopyrim.
A method of controlling insect pests, the method comprising: administering to a plant, seed, or soil a composition comprising a compound of Formula II or a salt thereof wherein R 10 is selected from the group consisting of phenyl, tolyl, naphtyl, phenanthrenyl, anthracentyl, indenyl, azulenyl, biphenyl, biphenylenyl, and fluorenyl and C 1 -C 10 alkyl; wherein R 11 is selected from the group consisting of phenyl, halophenyl, tolyl, napthyl, phenanthrenyl, anthracentyl, indenyl, azulenyl, biphenyl, biphenylenyl, and fluorenyl and 5- to 14-membered heteroaryl; wherein R 12 is selected from the group consisting of alkyl, alkenyl, alkynyl, C 1 -C 10 alkoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, methylcyclohexyl, cycloheptyl, azetidinyl, oxetanyl, tetrahydrofuranyl, dioxolinyl, pyrrolidinyl, pyrrolidinonyl, imidazolidinyl, pyrazolidinyl, pyrrolinyl tetrahydropyranyl, tetrahydrothiopyranyl, piperidinyl, morpholinyl, dithianyl, thiomorpholinyl, piperazinyl, trithianyl, and diazepanyl; and wherein Z is C 1 -C 6 alkyl or a bond. administering to a plant, seed, or soil a composition comprising a compound of Formula II or a salt thereof wherein R 10 is selected from the group consisting of phenyl, tolyl, naphtyl, phenanthrenyl, anthracentyl, indenyl, azulenyl, biphenyl, biphenylenyl, and fluorenyl and C 1 -C 10 alkyl; wherein R 11 is selected from the group consisting of phenyl, halophenyl, tolyl, napthyl, phenanthrenyl, anthracentyl, indenyl, azulenyl, biphenyl, biphenylenyl, and fluorenyl and 5- to 14-membered heteroaryl; wherein R 12 is selected from the group consisting of alkyl, alkenyl, alkynyl, C 1 -C 10 alkoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, methylcyclohexyl, cycloheptyl, azetidinyl, oxetanyl, tetrahydrofuranyl, dioxolinyl, pyrrolidinyl, pyrrolidinonyl, imidazolidinyl, pyrazolidinyl, pyrrolinyl tetrahydropyranyl, tetrahydrothiopyranyl, piperidinyl, morpholinyl, dithianyl, thiomorpholinyl, piperazinyl, trithianyl, and diazepanyl; and wherein Z is C 1 -C 6 alkyl or a bond.
An implantable medical device comprising: a hermetically sealed housing that is configured to enclose internal components, the internal components including: processing circuitry configured to at least one of control stimulation circuitry to deliver electrical stimulation using one or more leads received by the housing or control sensing circuitry to sense electrical signals using one or more leads received by the housing, telemetry circuitry , and a rechargeable power source , and a coil configured to at least one of receive energy to recharge the rechargeable power source or receive and/or transmit signals for wireless telemetry with another device, wherein the implantable medical device is configured to mount to a cranium of a patient; and characterized in that the coil has a tapered configuration within the housing such that the tapered coil has a narrowed portion defining a first coil height that is less than a second coil height of another portion of the tapered coil. a hermetically sealed housing that is configured to enclose internal components, the internal components including: processing circuitry configured to at least one of control stimulation circuitry to deliver electrical stimulation using one or more leads received by the housing or control sensing circuitry to sense electrical signals using one or more leads received by the housing, telemetry circuitry , and a rechargeable power source , and processing circuitry configured to at least one of control stimulation circuitry to deliver electrical stimulation using one or more leads received by the housing or control sensing circuitry to sense electrical signals using one or more leads received by the housing, telemetry circuitry , and a rechargeable power source , and a coil configured to at least one of receive energy to recharge the rechargeable power source or receive and/or transmit signals for wireless telemetry with another device, wherein the implantable medical device is configured to mount to a cranium of a patient; and characterized in that the coil has a tapered configuration within the housing such that the tapered coil has a narrowed portion defining a first coil height that is less than a second coil height of another portion of the tapered coil.
A method in an aggregator proxy function, APF, for providing a monitoring service, the method comprising the APF receiving , in a first Public Land Mobile Network, PLMN , a first event report transmitted by a monitoring function in the first PLMN , the first event report comprising first event information related to a monitoring event, and a request identifier; the APF receiving , a second event report transmitted by the monitoring function in the first PLMN , the second event report comprising second event information related to the monitoring event, and said request identifier; after receiving the first and second event reports, the APF transmitting an aggregate event report to a report receiving function not in the first PLMN , the aggregate event report comprising at least one of the first event information and the second event information, and said request identifier; and wherein the request identifier comprises an address of the report receiving function , characterized in that the method comprises: the APF receiving a permission request from the monitoring function ; the APF , in response to the permission request, transmitting a permission response to the monitoring function ; and the APF receiving the first event report and second event report from the monitoring function after transmitting the permission response. the APF receiving a permission request from the monitoring function ; the APF , in response to the permission request, transmitting a permission response to the monitoring function ; and the APF receiving the first event report and second event report from the monitoring function after transmitting the permission response.
An ultrasound imaging system comprising: an image processor that is configured to produce images of tissue being examined from received ultrasound signals; and a processor that is configured to: begin imaging by producing ultrasound signals with a transmit power level that is safe for sensitive tissues; analyze an image produced by the image processor for a representation of one or more anatomical features known to be present in an eye to determine if the tissue being imaged is sensitive tissue, wherein the sensitive tissue is ophthalmic tissue; in response to determining that the tissue is the sensitive tissue, confirm that the transmit power level is safe for imaging the sensitive tissue; and in response to determining that the tissue is not the sensitive tissue, increase the transmit power level of the ultrasound signals. an image processor that is configured to produce images of tissue being examined from received ultrasound signals; and a processor that is configured to: begin imaging by producing ultrasound signals with a transmit power level that is safe for sensitive tissues; analyze an image produced by the image processor for a representation of one or more anatomical features known to be present in an eye to determine if the tissue being imaged is sensitive tissue, wherein the sensitive tissue is ophthalmic tissue; in response to determining that the tissue is the sensitive tissue, confirm that the transmit power level is safe for imaging the sensitive tissue; and in response to determining that the tissue is not the sensitive tissue, increase the transmit power level of the ultrasound signals. begin imaging by producing ultrasound signals with a transmit power level that is safe for sensitive tissues; analyze an image produced by the image processor for a representation of one or more anatomical features known to be present in an eye to determine if the tissue being imaged is sensitive tissue, wherein the sensitive tissue is ophthalmic tissue; in response to determining that the tissue is the sensitive tissue, confirm that the transmit power level is safe for imaging the sensitive tissue; and in response to determining that the tissue is not the sensitive tissue, increase the transmit power level of the ultrasound signals.
Dry composition based on a mineral binder (a) and incorporating at least one SuperAbsorbent Polymer -SAP- (b) and a setting accelerating component (c), with this composition being intended for preparing a moist formulation for the building industry and characterised in that : • it comprises at least one source of aluminium ions; • the binder (a) is not a source of aluminium ions; • the component (c) comprises at least one source of aluminium ions; • the concentration in binder (a) is within the following concentration ranges, expressed as a % of dry weight of the composition and given in an increasing order of preference: [15- 99.5]; [20 - 98]; [25 - 97]; [25- 96]; [30 - 95]; • the concentration in component (c) is within the following concentration ranges, expressed as a % of dry weight of the composition and given in an increasing order of preference: [0.10- 20]; [0.15- 20]; [0.15- 15]; [0.15- 10]; [0.2- 10]. • it comprises at least one source of aluminium ions; • the binder (a) is not a source of aluminium ions; • the component (c) comprises at least one source of aluminium ions; • the concentration in binder (a) is within the following concentration ranges, expressed as a % of dry weight of the composition and given in an increasing order of preference: [15- 99.5]; [20 - 98]; [25 - 97]; [25- 96]; [30 - 95]; • the concentration in component (c) is within the following concentration ranges, expressed as a % of dry weight of the composition and given in an increasing order of preference: [0.10- 20]; [0.15- 20]; [0.15- 15]; [0.15- 10]; [0.2- 10].
A method for preparing a furan-based aromatic polyamide having a number average molecular weight more than 200,000 determined according to the method/s identified in the specification, the furan-based aromatic polyamide is derived from a diacid monomer comprising substituted or unsubstituted furandicarboxylic acid or derivatives thereof and a diamine monomer comprising substituted or unsubstituted 4,4'-diaminodiphenyl ether or derivatives thereof, and thus comprises a repeating unit of Formula (I) below: in Formula (I), R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are each independently H or a C 1-6 -alkyl, the method comprises: dissolving a diamine monomer comprising substituted or unsubstituted 4,4'-diaminodiphenyl ether or derivatives thereof in an organic solvent under the protection of an inert gas to form a diamine solution; adding a diacid monomer comprising substituted or unsubstituted furandicarboxylic acid or derivatives thereof, together with a catalyst of 2-(7-oxidebenzotriazolyl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, to the diamine solution at a temperature in a range of from -10°C to 30°C, so as to perform the reaction under stirring; and continuing the reaction until a furan-based aromatic polyamide with the desired molecular weight is obtained. in Formula (I), R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are each independently H or a C 1-6 -alkyl, the method comprises: dissolving a diamine monomer comprising substituted or unsubstituted 4,4'-diaminodiphenyl ether or derivatives thereof in an organic solvent under the protection of an inert gas to form a diamine solution; adding a diacid monomer comprising substituted or unsubstituted furandicarboxylic acid or derivatives thereof, together with a catalyst of 2-(7-oxidebenzotriazolyl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, to the diamine solution at a temperature in a range of from -10°C to 30°C, so as to perform the reaction under stirring; and continuing the reaction until a furan-based aromatic polyamide with the desired molecular weight is obtained. dissolving a diamine monomer comprising substituted or unsubstituted 4,4'-diaminodiphenyl ether or derivatives thereof in an organic solvent under the protection of an inert gas to form a diamine solution; adding a diacid monomer comprising substituted or unsubstituted furandicarboxylic acid or derivatives thereof, together with a catalyst of 2-(7-oxidebenzotriazolyl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, to the diamine solution at a temperature in a range of from -10°C to 30°C, so as to perform the reaction under stirring; and continuing the reaction until a furan-based aromatic polyamide with the desired molecular weight is obtained.
A method of detecting a target antibody isotype in a sample, the method comprising: a) contacting the sample with i) an antibody-binding agent comprising an antibody, an antibody mimetic, or an aptamer that specifically binds to the target antibody isotype, wherein the antibody-binding agent is conjugated to a first DNA molecule comprising a first portion of a barcode and ii) an antigen conjugated to a second DNA molecule comprising a second portion of a barcode, wherein the antigen binds to the target antibody isotype in the sample, if present, and the antibody-binding agent specifically binds to the target antibody isotype resulting in formation of a complex; b) connecting the first DNA molecule to the second DNA molecule in the complex, wherein the first portion of the barcode and the second portion of the barcode are joined to form a complete barcode; and c) detecting the complete barcode as an indication of the presence of the target antibody isotype in the sample. a) contacting the sample with i) an antibody-binding agent comprising an antibody, an antibody mimetic, or an aptamer that specifically binds to the target antibody isotype, wherein the antibody-binding agent is conjugated to a first DNA molecule comprising a first portion of a barcode and ii) an antigen conjugated to a second DNA molecule comprising a second portion of a barcode, wherein the antigen binds to the target antibody isotype in the sample, if present, and the antibody-binding agent specifically binds to the target antibody isotype resulting in formation of a complex; b) connecting the first DNA molecule to the second DNA molecule in the complex, wherein the first portion of the barcode and the second portion of the barcode are joined to form a complete barcode; and c) detecting the complete barcode as an indication of the presence of the target antibody isotype in the sample.